Announcement
Oriflame Cosmetics will publish its report for the first half-year 2010 at
07.15 CET on Wednesday, 11 August.
Conference call for the financial community
The company will host a conference call on Wednesday, 11 August at 10.30 CET.
Participant access numbers:
Sweden: +46 (0)8 506 269 00
UK: +44 (0)207 750 9905
US: +1 703 621 91 32
Luxemburg: +352 273 021 94
Switzerland: +41 (0)445 804 411
Confirmation code: 609705#
The conference call will also be audio web cast in "listen-only" mode through
Oriflame's website: www.oriflame.com or through Oriflame Zoom link to webcast.
[HUG#1435730]
PDF:
http://hugin.info/134730/R/1435730/381031.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Oriflame Cosmetics via Thomson Reuters ONE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.